More
    Guided Solutions - Connecting Talent With Innovation/div>

    Paige Receives First Ever FDA Approval for AI Product in Digital Pathology

    Paige Prostate analyzes digitized biopsy slides and identifies areas that could be cancerous for the pathologist to review further. Paige, a digital pathology diagnostics company, has received De Novo marketing authorization from the Food and Drug Administration...

    Paige Receives First Ever FDA Approval for AI Product in Digital Pathology

    Paige Prostate analyzes digitized biopsy slides and identifies areas that could be cancerous for the pathologist to review further. Paige, a digital pathology diagnostics company,...

    GE Healthcare to buy BK Medical for $1.45B

    GE Healthcare announced it will acquire BK Medical from private-equity firm Altaris Capital Partner for $1.45 billion to broaden the $3 billion ultrasound business into...

    Cryosa Closes $21.5 Million Series B Funding Round to Advance Minimally Invasive Obstructive Sleep Apnea Treatment

    Medical device startup Cryosa completed its Series B funding round, raising $21.5 million to continue development of its therapies for obstructive sleep apnea (OSA). The round was...

    Owen Mumford launches new Aidaptus auto-injector

    Owen Mumford Pharmaceutical Services, a division of Owen Mumford has launched its new Aidaptus auto-injector platform following successful completion of development. Aidaptus is a two-step, spring-powered,...

    Get Weekly Newsletter

    Finance

    Funding

    Clinical Trials

    Theraclion Receives FDA Approval for SONOVEIN Trial

    Theraclion has secured FDA (Food & Drug Administration) approval for the first trial with SONOVEIN in the United States (US). After this clinical trial, a full pivotal...

    Boston Scientific touts data from Phase 3 study of selective internal radiation therapy

    Boston Scientific (NYSE:BSX) touted data from a Phase 3 clinical trial of its TheraSphere Y-90 glass microspheres treatment. In the trial, the TheraSphere treatment successfully met...

    Cala Health wearables shown to decrease tremor movement

    Cala Health, a bioelectronic medicine company developing wearable therapies for chronic disease, announces two validating moments for the non-invasive prescription therapy for essential tremor...

    Study Update: OssDsign Synthetic Bone Graft

    OssDsign AB (publ) today announced that the first patient has been included in the company’s clinical study TOP FUSION to investigate the long-term safety...
    1,663FollowersFollow

    Innovation

    Regulatory Approvals

    Paige Receives First Ever FDA Approval for AI Product in Digital Pathology

    Paige Prostate analyzes digitized biopsy slides and identifies areas that could be cancerous for the pathologist to review further. Paige, a digital pathology diagnostics company,...

    GE Healthcare to buy BK Medical for $1.45B

    GE Healthcare announced it will acquire BK Medical from private-equity firm Altaris Capital Partner for $1.45 billion to broaden the $3 billion ultrasound business into...

    Cryosa Closes $21.5 Million Series B Funding Round to Advance Minimally Invasive Obstructive Sleep Apnea Treatment

    Medical device startup Cryosa completed its Series B funding round, raising $21.5 million to continue development of its therapies for obstructive sleep apnea (OSA). The round was...

    Owen Mumford launches new Aidaptus auto-injector

    Owen Mumford Pharmaceutical Services, a division of Owen Mumford has launched its new Aidaptus auto-injector platform following successful completion of development. Aidaptus is a two-step, spring-powered,...

    M&A

    Archives

    Latest articles